Addition of nimotuzumab to concurrent chemoradiotherapy after induction chemotherapy improves outcomes of patients with locally advanced nasopharyngeal carcinoma

Addition of nimotuzumab to concurrent chemoradiotherapy after induction chemotherapy improves outcomes of patients with locally advanced nasopharyngeal carcinoma

Purpose:To investigate the survival outcomes and toxicities associated with the addition of nimotuzumab to concurrent chemoradiotherapy (CCRT) in locally advanced nasopharyngeal carcinoma (LANPC) patients who received induction chemotherapy (IC).Methods:Patients with stage III-IVA nasopharyngeal car...

Full description

Bibliographic Details
Main Authors: Run-Jie Wang, Rui-Quan Ke, Yi-Feng Yu, Guan-Zhong Lu, San-Gang Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Pharmacology
Subjects:
nasopharyngeal carcinoma
anti-EGFR
nimotuzumab
outcome
radiotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1366853/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1366853/full

Similar Items